DeepX Health’s DermoSightTM and skin cancer teledermatology service featured in a great BBC video interview about skin cancer prevention in people of color, as part of the BBC Morning Live program. Following the story of a patient with dark skin, who was diagnosed and successfully treated for melanoma, presenter Rhys Stephenson headed to a Boots pharmacy to have a mole scanned with DermoSight. Luckily, he was relieved to learn that he did not have melanoma, when the service sent him his diagnosis directly on his phone.
To watch the segment about the skin cancer prevention service with DermoSight available at Boots, please follow this link and tune in from 20’33”.
DermoSight is a digital dermatoscope to acquire skin lesion images for teledermatology assessment. It is currently being used in primary care, as part of NHS services in GP clinics and in community pharmacies in the UK and in Europe, including the Walgreens Boots Alliance pharmacy chain Boots. DeepX Health has so far preformed about 180 thousand teledermoscopy assessments of skin lesions through its services offered to concerned consumers and doctors.
For more information about DermoSight: www.dermosight.com
DeepX Health’s DermoSight at NHS event on 12 JulyRead more
DeepX Diagnostics Inc.'s DermoSight Receives FDA Clearance for Teledermatology Screening of Suspect Skin Cancer LesionsRead more
DeepX Health’s Skin Cancer Teledermoscopy Services Now in JerseyRead more
New Board Advisor to DeepX HealthRead more
New Head of Product at DeepX HealthRead more
DeepX Health selected to present at Nordic Life Science DaysRead more
Pharmacy Screening Demonstrates Great Efficiency and Potential for Cost ReductionsRead more
Primary Care Setting Pilot Launched with NHSRead more
DeepX Health to Present at the 8th World Congress of Teledermatology, Imaging and Artificial Intelligence for Skin DiseasesRead more
ScreenCancer Awarded Support for Diagnostic Triage Algorithm-ProjectRead more
DeepX Health to participate at the 7th Annual Dermatology Summit in San FranciscoRead more
DeepX Health to present at Digital Health World Congress in LondonRead more
DeepX Health participate in the DxPx ConferenceRead more
ScreenCancer approved for first round of Horizon 2020 programmeRead more